165 related articles for article (PubMed ID: 17140722)
1. Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
Choo R; Pearce A; Danjoux C; Morton G; Deboer G; Szumacher E; Loblaw A; Cheung P
Eur Urol; 2007 Dec; 52(6):1645-50. PubMed ID: 17140722
[TBL] [Abstract][Full Text] [Related]
2. Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy.
Pearce A; Choo R; Danjoux C; Morton G; Loblaw DA; Szumacher E; Cheung P; Deboer G; Chander S
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):78-83. PubMed ID: 16563657
[TBL] [Abstract][Full Text] [Related]
3. A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy.
Yoshimura K; Arai Y; Ichioka K; Matsui Y; Ogura K; Terai A
Prostate Cancer Prostatic Dis; 2004; 7(2):144-51. PubMed ID: 15111981
[TBL] [Abstract][Full Text] [Related]
4. Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.
Choo R; Danjoux C; Gardner S; Morton G; Szumacher E; Loblaw DA; Cheung P; Pearse M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):407-12. PubMed ID: 19211197
[TBL] [Abstract][Full Text] [Related]
5. Editorial comment on: Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
de Reijke TM
Eur Urol; 2007 Dec; 52(6):1650-1. PubMed ID: 18074436
[No Abstract] [Full Text] [Related]
6. Editorial comment on: Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
Parker C
Eur Urol; 2007 Dec; 52(6):1651-2. PubMed ID: 18074437
[No Abstract] [Full Text] [Related]
7. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
Moinpour CM; Hayden KA; Unger JM; Thompson IM; Redman MW; Canby-Hagino ED; Higgins BA; Sullivan JW; Lemmon D; Breslin S; Crawford ED; Southwest Oncology Group
J Clin Oncol; 2008 Jan; 26(1):112-20. PubMed ID: 18165645
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.
Truong PT; Berthelet E; Lee JC; Petersen R; Lim JT; Gaul CA; Pai H; Blood P; Ludgate CM
Can J Urol; 2006 Jun; 13(3):3139-46. PubMed ID: 16813705
[TBL] [Abstract][Full Text] [Related]
9. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
Wiegel T; Bottke D; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Souchon R; Stöckle M; Rübe C; Weissbach L; Althaus P; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hinke A; Hinkelbein W; Miller K
J Clin Oncol; 2009 Jun; 27(18):2924-30. PubMed ID: 19433689
[TBL] [Abstract][Full Text] [Related]
10. Cross-sectional survey of long-term quality of life after radical perineal prostatectomy.
Yang BK; Crisci A; Young MD; Silverstein AD; Peterson BL; Dahm P
Urology; 2005 Jan; 65(1):120-5. PubMed ID: 15667876
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
12. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia.
Van Vulpen M; De Leeuw JR; Van Gellekom MP; Van Der Hoeven J; De Graeff A; Van Moorselaar RJ; Van Der Tweel I; Hofman P; Lagendijk JJ; Battermann JJ
Int J Hyperthermia; 2003; 19(4):402-13. PubMed ID: 12850926
[TBL] [Abstract][Full Text] [Related]
13. Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery.
Chander S; Choo R; Danjoux C; Morton G; Pearse A; Deboer G; Szumacher E; Loblaw A; Cheung P; Woo T
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):719-24. PubMed ID: 15936551
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life after radical prostatectomy and low-dose-rate brachytherapy for localized prostate cancer.
Wyler SF; Engeler DS; Seelentag W; Ries G; Schmid HP
Urol Int; 2009; 82(1):17-23. PubMed ID: 19172091
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up after triple treatment of prostate cancer stage pT3.
Schelin S; Madsen M; Palmqvist E; Mäkelä E; Klintenberg C; Aus G
Scand J Urol Nephrol; 2009; 43(3):186-91. PubMed ID: 19353383
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
[TBL] [Abstract][Full Text] [Related]
17. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
Bradley EB; Bissonette EA; Theodorescu D
BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
[TBL] [Abstract][Full Text] [Related]
18. Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy.
Krahn MD; Bremner KE; Tomlinson G; Naglie G
Prostate Cancer Prostatic Dis; 2009; 12(4):361-8. PubMed ID: 19901935
[TBL] [Abstract][Full Text] [Related]
19. Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting.
Berge V; Thompson T; Blackman D
Scand J Urol Nephrol; 2007; 41(3):198-203. PubMed ID: 17469027
[TBL] [Abstract][Full Text] [Related]
20. Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?
Pai HH; Eldridge B; Bishop D; Alexander A; Lesperance M; Blood P; Lim J; Ludgate C
Can J Urol; 2009 Apr; 16(2):4541-52. PubMed ID: 19364426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
